Acquisitions Purchase
Pharmaceuticals Acquisitions in 2024
Review the export, choose years, and enter your email to continue.
Full Export
Purchase the full list for Pharmaceuticals Acquisitions in 2024
54 rows · from $54 · CSV + XLSX
Show details
Hide details
Full Export
Purchase the full list for Pharmaceuticals Acquisitions in 2024
54 rows · from $54 · CSV + XLSX
Get a point-in-time export of all tracked rows for this page. We email the file immediately after purchase.
What the export looks like
| Date | Title | Buyers | Targets | Industry | Transaction Type | Location | Closing Status |
|---|---|---|---|---|---|---|---|
| 2024-12-09 | Zentiva Completes Voluntary Public Purchase Offer for APONTIS PHARMA AG | Zentiva AG | APONTIS PHARMA AG | Pharmaceuticals | Buyout | Germany | Confirmed closed |
| 2024-11-29 | CBC Group and Mubadala Acquire UCB's Mature China Neurology & Allergy Portfolio to Create NeuroGen Pharma | CBC Group; Mubadala Investment Company | UCB mature neurology and allergy business in China (transferred into NeuroGen Pharma) | Pharmaceuticals | Buyout | Guangdong, China | Confirmed closed |
| 2024-10-29 | 1315 Capital Leads Growth Investment in Experic | 1315 Capital; East Seattle Partners; Harro Höfliger Packaging Systems, Inc.; Kineticos Ventures | Experic | Pharmaceuticals | Growth capital | New Jersey, United States | Confirmed closed |
Each purchase includes both CSV and XLSX files, emailed to you immediately.